Does atorvastatin treatment improve survival and effects of implanted mesenchymal stem cells in post-infarct swine hearts?
Ator treatment may protect the myocardium undergoing acute infarction and reperfusion by creating a better environment for the survival and differentiation of implanted MSCs. The benefit of the Ator/stem cell combined therapy may result from the statin-mediated inhibition of apoptosis, oxidative stress, and inflammation in the infarcted myocardium.
BMD shows that optimal bone density is found in the anatomic insertion area of the coracoclavicular ligaments between 20 mm and 50 mm from the lateral end of the clavicle. Low BMD correlated with decreased load to failure.